{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T16:29:22Z","timestamp":1794155362233,"version":"4.8.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NSF Graduate Research Fellowship Program","award":["DGE1745016"],"award-info":[{"award-number":["DGE1745016"]}]},{"name":"Translate Bio","id":[{"id":"https:\/\/ror.org\/02tzsc576","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Defense Advanced Research Projects Agency","award":["HR0011-19-2-0007"],"award-info":[{"award-number":["HR0011-19-2-0007"]}],"id":[{"id":"https:\/\/ror.org\/02caytj08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Defense Advanced Research Projects Agency","award":["HR0011-19-2-0007"],"award-info":[{"award-number":["HR0011-19-2-0007"]}],"id":[{"id":"https:\/\/ror.org\/02caytj08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Defense Advanced Research Projects Agency","award":["HR0011-19-2-0007"],"award-info":[{"award-number":["HR0011-19-2-0007"]}],"id":[{"id":"https:\/\/ror.org\/02caytj08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Defense Advanced Research Projects Agency","award":["HR0011-19-2-0007"],"award-info":[{"award-number":["HR0011-19-2-0007"]}],"id":[{"id":"https:\/\/ror.org\/02caytj08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Defense Advanced Research Projects Agency","award":["HR0011-19-2-0007"],"award-info":[{"award-number":["HR0011-19-2-0007"]}],"id":[{"id":"https:\/\/ror.org\/02caytj08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Defense Advanced Research Projects Agency","award":["HR0011-19-2-0007"],"award-info":[{"award-number":["HR0011-19-2-0007"]}],"id":[{"id":"https:\/\/ror.org\/02caytj08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Defense Advanced Research Projects Agency","award":["HR0011-19-2-0007"],"award-info":[{"award-number":["HR0011-19-2-0007"]}],"id":[{"id":"https:\/\/ror.org\/02caytj08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Defense Advanced Research Projects Agency","award":["HR0011-19-2-0007"],"award-info":[{"award-number":["HR0011-19-2-0007"]}],"id":[{"id":"https:\/\/ror.org\/02caytj08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Defense Advanced Research Projects Agency","award":["HR0011-19-2-0007"],"award-info":[{"award-number":["HR0011-19-2-0007"]}],"id":[{"id":"https:\/\/ror.org\/02caytj08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Wadhwani Foundation"},{"name":"NIH F32 fellowship","award":["1F32EB029345"],"award-info":[{"award-number":["1F32EB029345"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"DOI":"10.1007\/s13346-026-02225-3","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:43:07Z","timestamp":1791826987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PEG-associated efficacy loss in lipid nanoparticles persists across formulation modifications for mRNA delivery"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3248-4068","authenticated-orcid":false,"given":"Mariah L.","family":"Arral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2115-7731","authenticated-orcid":false,"given":"Namit","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3430-9191","authenticated-orcid":false,"given":"Katherine C.","family":"Fein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1812-4744","authenticated-orcid":false,"given":"Alexandra N.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9100-9818","authenticated-orcid":false,"given":"Saigopalakrishna S.","family":"Yerneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0364-9334","authenticated-orcid":false,"given":"Jilian R.","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9941-7935","authenticated-orcid":false,"given":"Samuel T.","family":"LoPresti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7783-161X","authenticated-orcid":false,"given":"Daria M.","family":"Strelkova Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0100-7824","authenticated-orcid":false,"given":"Kathryn A.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"2225_CR1","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMOA2110475\/SUPPL_FILE\/NEJMOA2110475_DISCLOSURES.PDF","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med. 2021;385:1078\u201390. https:\/\/doi.org\/10.1056\/NEJMOA2110475\/SUPPL_FILE\/NEJMOA2110475_DISCLOSURES.PDF","journal-title":"N Engl J Med"},{"key":"2225_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384:403\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2035389","journal-title":"N Engl J Med"},{"key":"2225_CR3","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","volume":"383","author":"EJ Anderson","year":"2020","unstructured":"Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, et al. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. N Engl J Med. 2020;383:2427\u201338. https:\/\/doi.org\/10.1056\/NEJMoa2028436","journal-title":"N Engl J Med"},{"key":"2225_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature21428","volume":"543","author":"N Pardi","year":"2017","unstructured":"Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017;543:248\u201351. https:\/\/doi.org\/10.1038\/nature21428","journal-title":"Nature"},{"key":"2225_CR5","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1126\/SCITRANSLMED.AAV5701","volume":"12","author":"E Willis","year":"2020","unstructured":"Willis E, Pardi N, Parkhouse K, Mui BL, Tam YK, Weissman D, et al. Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice. Sci Transl Med. 2020;12:5701 https:\/\/doi.org\/10.1126\/SCITRANSLMED.AAV5701","journal-title":"Sci Transl Med"},{"key":"2225_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/J.YMTHE.2017.12.024","volume":"26","author":"MG Prieve","year":"2018","unstructured":"Prieve MG, Harvie P, Monahan SD, Roy D, Li AG, Blevins TL, et al. Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency. Mol Ther. 2018;26:801\u201313. https:\/\/doi.org\/10.1016\/J.YMTHE.2017.12.024","journal-title":"Mol Ther"},{"key":"2225_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64017-0","volume":"10","author":"A Karadagi","year":"2020","unstructured":"Karadagi A, Cavedon AG, Zemack H, Nowak G, Eybye ME, Zhu X, et al. Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency. Sci Rep. 2020;10:7052 https:\/\/doi.org\/10.1038\/s41598-020-64017-0","journal-title":"Sci Rep"},{"key":"2225_CR8","doi-asserted-by":"publisher","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","volume":"114","author":"S Ramaswamy","year":"2017","unstructured":"Ramaswamy S, Tonnu N, Tachikawa K, Limphong P, Vega JB, Karmali PP, et al. Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proc Natl Acad Sci. 2017;114:E1941\u201350. https:\/\/doi.org\/10.1073\/pnas.1619653114","journal-title":"Proc Natl Acad Sci"},{"key":"2225_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-42948-2","volume":"14","author":"T Wei","year":"2023","unstructured":"Wei T, Sun Y, Cheng Q, Chatterjee S, Traylor Z, Johnson LT, et al. Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models. Nat Commun. 2023;14:1\u201314. https:\/\/doi.org\/10.1038\/s41467-023-42948-2","journal-title":"Nat Commun"},{"key":"2225_CR10","doi-asserted-by":"publisher","first-page":"13594","DOI":"10.1021\/acsnano.3c02268","volume":"17","author":"R Palanki","year":"2023","unstructured":"Palanki R, Bose SK, Dave A, White BM, Berkowitz C, Luks V, et al. Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain Disease. ACS Nano. 2023;17:13594\u2013610. https:\/\/doi.org\/10.1021\/acsnano.3c02268","journal-title":"ACS Nano"},{"key":"2225_CR11","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1021\/acs.nanolett.9b04246","volume":"20","author":"MM Billingsley","year":"2020","unstructured":"Billingsley MM, Singh N, Ravikumar P, Zhang R, June CH, Mitchell MJ. Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering. Nano Lett. 2020;20:1578\u201389. https:\/\/doi.org\/10.1021\/acs.nanolett.9b04246","journal-title":"Nano Lett"},{"key":"2225_CR12","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","volume":"17","author":"MA Oberli","year":"2017","unstructured":"Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, et al. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017;17:1326\u201335. https:\/\/doi.org\/10.1021\/acs.nanolett.6b03329","journal-title":"Nano Lett"},{"key":"2225_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/J.JCONREL.2022.03.021","volume":"345","author":"JQ Liu","year":"2022","unstructured":"Liu JQ, Zhang C, Zhang X, Yan J, Zeng C, Talebian F, et al. Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy. J Control Release. 2022;345:306\u201313. https:\/\/doi.org\/10.1016\/J.JCONREL.2022.03.021","journal-title":"J Control Release"},{"key":"2225_CR14","doi-asserted-by":"publisher","unstructured":"Arral ML, Whitehead KA Design principles of lipid nanoparticles for RNA delivery. Nat Rev Bioeng. 2026;1\u201318. https:\/\/doi.org\/10.1038\/s44222-026-00401-1","DOI":"10.1038\/s44222-026-00401-1"},{"key":"2225_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","volume":"99","author":"X Cheng","year":"2016","unstructured":"Cheng X, Lee RJ. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. Adv Drug Deliv Rev. 2016;99:129\u201337. https:\/\/doi.org\/10.1016\/j.addr.2016.01.022","journal-title":"Adv Drug Deliv Rev"},{"key":"2225_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/J.JCONREL.2021.05.021","volume":"335","author":"KJ Hassett","year":"2021","unstructured":"Hassett KJ, Higgins J, Woods A, Levy B, Xia Y, Hsiao CJ, et al. Impact of lipid nanoparticle size on mRNA vaccine immunogenicity. J Control Release. 2021;335:237\u201346. https:\/\/doi.org\/10.1016\/J.JCONREL.2021.05.021","journal-title":"J Control Release"},{"key":"2225_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/pharmaceutics15020597","volume":"15","author":"M Berger","year":"2023","unstructured":"Berger M, Degey M, Leblond Chain J, Maquoi E, Evrard B, Lechanteur A, et al. Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics. 2023;15:597 https:\/\/doi.org\/10.3390\/pharmaceutics15020597","journal-title":"Pharmaceutics"},{"key":"2225_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.61","volume":"3","author":"V Kumar","year":"2014","unstructured":"Kumar V, Qin J, Jiang Y, Duncan RG, Brigham B, Fishman S, et al. Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy. Mol Ther Nucleic Acids. 2014;3:e210 https:\/\/doi.org\/10.1038\/mtna.2014.61","journal-title":"Mol Ther Nucleic Acids"},{"key":"2225_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2020.119792","volume":"588","author":"T Suzuki","year":"2020","unstructured":"Suzuki T, Suzuki Y, Hihara T, Kubara K, Kondo K, Hyodo K, et al. PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production. Int J Pharm. 2020;588:119792 https:\/\/doi.org\/10.1016\/J.IJPHARM.2020.119792","journal-title":"Int J Pharm"},{"key":"2225_CR20","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1021\/acs.nanolett.8b01101","volume":"18","author":"RL Ball","year":"2018","unstructured":"Ball RL, Hajj KA, Vizelman J, Bajaj P, Whitehead KA. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA. Nano Lett. 2018;18:3814\u201322. https:\/\/doi.org\/10.1021\/acs.nanolett.8b01101","journal-title":"Nano Lett"},{"key":"2225_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/J.JCONREL.2021.11.022","volume":"341","author":"JR Melamed","year":"2022","unstructured":"Melamed JR, Hajj KA, Chaudhary N, Strelkova D, Arral ML, Pardi N, et al. Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery. J Control Release. 2022;341:206\u201314. https:\/\/doi.org\/10.1016\/J.JCONREL.2021.11.022","journal-title":"J Control Release"},{"key":"2225_CR22","doi-asserted-by":"publisher","first-page":"E9944","DOI":"10.1073\/pnas.1811276115","volume":"115","author":"CD Sago","year":"2018","unstructured":"Sago CD, Lokugamage MP, Paunovska K, Vanover DA, Monaco CM, Shah NN, et al. High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing. Proc Natl Acad Sci. 2018;115:E9944\u201352. https:\/\/doi.org\/10.1073\/pnas.1811276115","journal-title":"Proc Natl Acad Sci"},{"key":"2225_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/NBT.3471","volume":"34","author":"H Yin","year":"2016","unstructured":"Yin H, Song CQ, Dorkin JR, Zhu LJ, Li Y, Wu Q, et al. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol. 2016;34:328 https:\/\/doi.org\/10.1038\/NBT.3471","journal-title":"Nat Biotechnol"},{"key":"2225_CR24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jconrel.2021.10.031","volume":"341","author":"KL Swingle","year":"2022","unstructured":"Swingle KL, Billingsley MM, Bose SK, White B, Palanki R, Dave A, et al. Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery. J Control Release. 2022;341:616\u201333. https:\/\/doi.org\/10.1016\/j.jconrel.2021.10.031","journal-title":"J Control Release"},{"key":"2225_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2017.56","volume":"2","author":"KA Hajj","year":"2017","unstructured":"Hajj KA, Whitehead KA. Tools for translation: non-viral materials for therapeutic mRNA delivery. Nat Rev Mater. 2017;2:17056 https:\/\/doi.org\/10.1038\/natrevmats.2017.56","journal-title":"Nat Rev Mater"},{"key":"2225_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4049\/immunohorizons.1900029","volume":"3","author":"G Besin","year":"2019","unstructured":"Besin G, Milton J, Sabnis S, Howell R, Mihai C, Burke K, et al. Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocytes to Distinct Antigenic Moieties. Immunohorizons. 2019;3:282\u201393. https:\/\/doi.org\/10.4049\/immunohorizons.1900029","journal-title":"Immunohorizons"},{"key":"2225_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/J.JCONREL.2013.07.026","volume":"172","author":"AS Abu Lila","year":"2013","unstructured":"Abu Lila AS, Kiwada H, Ishida T. The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage. J Control Release. 2013;172:38\u201347. https:\/\/doi.org\/10.1016\/J.JCONREL.2013.07.026","journal-title":"J Control Release"},{"key":"2225_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/J.JCONREL.2020.03.022","volume":"322","author":"K Son","year":"2020","unstructured":"Son K, Ueda M, Taguchi K, Maruyama T, Takeoka S, Ito Y. Evasion of the accelerated blood clearance phenomenon by polysarcosine coating of liposomes. J Control Release. 2020;322:209\u201316. https:\/\/doi.org\/10.1016\/J.JCONREL.2020.03.022","journal-title":"J Control Release"},{"key":"2225_CR29","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","volume":"292","author":"E Dams","year":"2000","unstructured":"Dams E, Laverman P, Oyen W, Storm G, Scherphof G, van Der Meer JW, et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther. 2000;292:1071\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"2225_CR30","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","volume":"8","author":"N Chaudhary","year":"2024","unstructured":"Chaudhary N, Kasiewicz LN, Newby AN, Arral ML, Yerneni SS, Melamed JR, et al. Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d. Nat Biomed Eng. 2024;8:1483\u201398. https:\/\/doi.org\/10.1038\/s41551-024-01256-w","journal-title":"Nat Biomed Eng"},{"key":"2225_CR31","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/s41563-025-02383-8","volume":"24","author":"N Chaudhary","year":"2025","unstructured":"Chaudhary N, Whitehead KA. Designing around immune memory to counter PEG immunogenicity. Nat Mater. 2025;24:1666\u20139. https:\/\/doi.org\/10.1038\/s41563-025-02383-8","journal-title":"Nat Mater"},{"key":"2225_CR32","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1073\/PNAS.0813411106\/SUPPL_FILE\/0813411106SI.PDF","volume":"106","author":"LE Cole","year":"2009","unstructured":"Cole LE, Yang Y, Elkins KL, Fernandez ET, Qureshi N, Shlomchik MJ, et al. Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protect i on aga i nst F. tularensis LVS challenge. Proc Natl Acad Sci USA. 2009;106:4343\u20138. https:\/\/doi.org\/10.1073\/PNAS.0813411106\/SUPPL_FILE\/0813411106SI.PDF","journal-title":"Proc Natl Acad Sci USA"},{"key":"2225_CR33","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/JEM.20171450","volume":"215","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Naradikian MS, Parkhouse K, Cain DW, Jones L, et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J Exp Med. 2018;215:1571\u201388. https:\/\/doi.org\/10.1084\/JEM.20171450","journal-title":"J Exp Med"},{"key":"2225_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16248-y","volume":"11","author":"L Miao","year":"2020","unstructured":"Miao L, Lin J, Huang Y, Li L, Delcassian D, Ge Y, et al. Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver. Nat Commun. 2020;11:1\u201313. https:\/\/doi.org\/10.1038\/s41467-020-16248-y","journal-title":"Nat Commun"},{"key":"2225_CR35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard SA, Cheng Q, Siegwart DJ. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc Natl Acad Sci. 2021;118:e2109256118 https:\/\/doi.org\/10.1073\/pnas.2109256118","journal-title":"Proc Natl Acad Sci"},{"key":"2225_CR36","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1182\/blood.V81.3.617.617","volume":"81","author":"J Fandrey","year":"1993","unstructured":"Fandrey J, Bunn H. In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood. 1993;81:617\u201323. https:\/\/doi.org\/10.1182\/blood.V81.3.617.617","journal-title":"Blood"},{"key":"2225_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400225","volume":"13","author":"DMS Petersen","year":"2024","unstructured":"Petersen DMS, Weiss RM, Hajj KA, Yerneni SS, Chaudhary N, Newby AN, et al. Branched\u2010Tail Lipid Nanoparticles for Intravenous mRNA Delivery to Lung Immune, Endothelial, and Alveolar Cells in Mice. Adv Heal Mater. 2024;13:2400225 https:\/\/doi.org\/10.1002\/adhm.202400225","journal-title":"Adv Heal Mater"},{"key":"2225_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201805097","volume":"15","author":"KA Hajj","year":"2019","unstructured":"Hajj KA, Ball RL, Deluty SB, Singh SR, Strelkova D, Knapp CM, et al. Branched\u2010Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pH. Small. 2019;15:1805097 https:\/\/doi.org\/10.1002\/smll.201805097","journal-title":"Small"},{"key":"2225_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12865-021-00448-2","volume":"22","author":"A Santaolalla","year":"2021","unstructured":"Santaolalla A, Sollie S, Rislan A, Josephs DH, Hammar N, Walldius G, et al. Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study. BMC Immunol. 2021;22:61 https:\/\/doi.org\/10.1186\/s12865-021-00448-2","journal-title":"BMC Immunol"},{"key":"2225_CR40","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.4049\/JIMMUNOL.1401849","volume":"193","author":"J Stavnezer","year":"2014","unstructured":"Stavnezer J, Schrader CE. Ig heavy chain class switch recombination: mechanism and regulation. J Immunol. 2014;193:5370 https:\/\/doi.org\/10.4049\/JIMMUNOL.1401849","journal-title":"J Immunol"},{"key":"2225_CR41","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov. 2021;20:817\u201338. https:\/\/doi.org\/10.1038\/s41573-021-00283-5","journal-title":"Nat Rev Drug Discov"},{"key":"2225_CR42","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1021\/acs.nanolett.0c00596","volume":"20","author":"KA Hajj","year":"2020","unstructured":"Hajj KA, Melamed JR, Chaudhary N, Lamson NG, Ball RL, Yerneni SS, et al. A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo. Khalid Nano Lett. 2020;20:5167\u201375. https:\/\/doi.org\/10.1021\/acs.nanolett.0c00596","journal-title":"Khalid Nano Lett"},{"key":"2225_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade1444","volume":"9","author":"JR Melamed","year":"2023","unstructured":"Melamed JR, Yerneni SS, Arral ML, LoPresti ST, Chaudhary N, Sehrawat A, et al. Ionizable lipid nanoparticles deliver mRNA to pancreatic \u03b2 cells via macrophage-mediated gene transfer. Sci Adv. 2023;9:eade1444 https:\/\/doi.org\/10.1126\/sciadv.ade1444","journal-title":"Sci Adv"},{"key":"2225_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/ACS.ACCOUNTS.1C00544\/ASSET\/IMAGES\/LARGE\/AR1C00544_0005.JPEG","volume":"55","author":"Y Eygeris","year":"2022","unstructured":"Eygeris Y, Gupta M, Kim J, Sahay G. Chemistry of Lipid Nanoparticles for RNA Delivery. Acc Chem Res. 2022;55:2\u201312. https:\/\/doi.org\/10.1021\/ACS.ACCOUNTS.1C00544\/ASSET\/IMAGES\/LARGE\/AR1C00544_0005.JPEG","journal-title":"Acc Chem Res"},{"key":"2225_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int J Pharm. 2021;601:120586 https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120586","journal-title":"Int J Pharm"},{"key":"2225_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JCONREL.2023.02.021","volume":"356","author":"D Bi","year":"2023","unstructured":"Bi D, Unthan DM, Hu L, Bussmann J, Remaut K, Barz M, et al. Polysarcosine-based lipid formulations for intracranial delivery of mRNA. J Control Release. 2023;356:1\u201313. https:\/\/doi.org\/10.1016\/J.JCONREL.2023.02.021","journal-title":"J Control Release"},{"key":"2225_CR47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/J.BIOACTMAT.2024.03.017","volume":"37","author":"DD Kang","year":"2024","unstructured":"Kang DD, Hou X, Wang L, Xue Y, Li H, Zhong Y, et al. Engineering LNPs with polysarcosine lipids for mRNA delivery. Bioact Mater. 2024;37:86\u201393. https:\/\/doi.org\/10.1016\/J.BIOACTMAT.2024.03.017","journal-title":"Bioact Mater"},{"key":"2225_CR48","doi-asserted-by":"publisher","unstructured":"Xiao Y, Lian X, Sun Y, Sung YC, Vaidya A, Chen Z, et al. High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics. Nat Mater 2025;1\u201312. https:\/\/doi.org\/10.1038\/S41563-024-02116-3;SUBJMETA","DOI":"10.1038\/S41563-024-02116-3;SUBJMETA"},{"key":"2225_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-022-33157-4","volume":"13","author":"S Li","year":"2022","unstructured":"Li S, Hu Y, Li A, Lin J, Hsieh K, Schneiderman Z, et al. Payload distribution and capacity of mRNA lipid nanoparticles. Nat Commun. 2022;13:5561 https:\/\/doi.org\/10.1038\/S41467-022-33157-4","journal-title":"Nat Commun"},{"key":"2225_CR50","doi-asserted-by":"publisher","first-page":"11329","DOI":"10.1039\/D5NR00433K","volume":"17","author":"L Liu","year":"2025","unstructured":"Liu L, Kim JH, Li Z, Sun M, Northen T, Tang J, et al. PEGylated lipid screening, composition optimization, and structure\u2013activity relationship determination for lipid nanoparticle-mediated mRNA delivery. Nanoscale. 2025;17:11329\u201344. https:\/\/doi.org\/10.1039\/D5NR00433K","journal-title":"Nanoscale"},{"key":"2225_CR51","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41582-018-0065-0","volume":"14","author":"H Wood","year":"2018","unstructured":"Wood H. FDA approves patisiran to treat hereditary transthyretin amyloidosis. Nat Rev Neurol. 2018;14:570\u2013570. https:\/\/doi.org\/10.1038\/s41582-018-0065-0","journal-title":"Nat Rev Neurol"},{"key":"2225_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD, Yang C-C, Ueda M, Kristen AV, et al. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. N Engl J Med. 2018;379:11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1716153","journal-title":"N Engl J Med"},{"key":"2225_CR53","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","volume":"9","author":"RP Garay","year":"2012","unstructured":"Garay RP, El-Gewely R, Armstrong JK, Garratty G, Richette P. Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents. Expert Opin Drug Deliv. 2012;9:1319\u201323. https:\/\/doi.org\/10.1517\/17425247.2012.720969","journal-title":"Expert Opin Drug Deliv"},{"key":"2225_CR54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/J.JCONREL.2022.09.031","volume":"351","author":"M Ibrahim","year":"2022","unstructured":"Ibrahim M, Ramadan E, Elsadek NE, Emam SE, Shimizu T, Ando H, et al. Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products. J Control Release. 2022;351:215\u201330. https:\/\/doi.org\/10.1016\/J.JCONREL.2022.09.031","journal-title":"J Control Release"},{"key":"2225_CR55","doi-asserted-by":"publisher","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","volume":"16","author":"Y Ju","year":"2022","unstructured":"Ju Y, Lee WS, Pilkington EH, Kelly HG, Li S, Selva KJ, et al. Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine. ACS Nano. 2022;16:11769\u201380. https:\/\/doi.org\/10.1021\/acsnano.2c04543","journal-title":"ACS Nano"},{"key":"2225_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13223-022-00698-8\/METRICS","volume":"18","author":"DH Li","year":"2022","unstructured":"Li DH, Lee E, Song C. Successful mRNA COVID-19 vaccination in a patient with a history of severe polyethylene glycol anaphylaxis. Allergy, Asthma Clin Immunol. 2022;18:1 https:\/\/doi.org\/10.1186\/S13223-022-00698-8\/METRICS","journal-title":"Allergy, Asthma Clin Immunol"},{"key":"2225_CR57","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jaip.2021.11.021","volume":"10","author":"M Picard","year":"2022","unstructured":"Picard M, Drolet J-P, Masse M-S, Filion CA, ALMuhizi F, Fein M, et al. Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series. J Allergy Clin Immunol Pract. 2022;10:620\u20135.e1. https:\/\/doi.org\/10.1016\/j.jaip.2021.11.021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2225_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5277","volume":"5","author":"KA Whitehead","year":"2014","unstructured":"Whitehead KA, Dorkin JR, Vegas AJ, Chang PH, Veiseh O, Matthews J, et al. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nat Commun. 2014;5:4277 https:\/\/doi.org\/10.1038\/ncomms5277","journal-title":"Nat Commun"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02225-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02225-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02225-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:02:40Z","timestamp":1791968560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02225-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":58,"alternative-id":["2225"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02225-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9763025\/v1","asserted-by":"object"}]},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.A.W. is an inventor on US patents 9,227,917 (2016) and 9,439,968 (2016) related to the lipid nanoparticles described here and is a consultant for several companies translating nonviral RNA delivery systems.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}